SU = sulfonylurea a Ontario prices presented Source: Sponsors pharmacoeconomic submission 1 Results of the sponsors base case suggested an incremental cost of $3,355,258 in Year 1, $10,231,784 in Year 2, and $21,706,463 in Year 3, for a total incremental cost of $35,293,505 over the 3-year time horizon, when oral semaglutide is reimbursed as an adjunct to diet and exercise to improve glycemic control in adults with T2DM as monotherapy when metformin is considered inappropriate due to intolerance or contraindications or in combination with other medicinal products
How Long Does the Injection Take
From the manufacturing perspective, this level of international reach usually indicates that a company has already developed systems capable of handling export documentation, regulatory standards, and cross-border logistics
However, symptom duration varies
CD26, Let it Cut or Cut it Down